Evolent Health, Inc. - EVH

SEC Filings Our EVH Tweets

About Gravity Analytica

Recent News

  • 11.04.2026 - Streamlining Prior Authorization for Patients
  • 10.20.2026 - Mary Daniel
  • 10.20.2026 - Ana Best
  • 10.20.2026 - Aaron Werner
  • 10.20.2026 - Ty J. Gluckman, MD, MHA, FACC, FAHA, FASPC
  • 10.19.2026 - Squamous Cell Skin Cancer
  • 10.15.2026 - Stephen “Fred” Divers, MD
  • 09.09.2026 - Evolent program flags low-value regimen years ahead of failed clinical trial
  • 08.31.2026 - Aligning oncology incentives to drive high-value cancer care
  • 07.24.2026 - Physical Medicine Train-the-Trainer Guide

Recent Filings

  • 11.05.2026 - 8-K Current report
  • 11.05.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 11.05.2026 - EX-99.1 EX-99.1
  • 09.08.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
  • 08.28.2026 - 4 Statement of changes in beneficial ownership of securities
  • 08.26.2026 - 144 Report of proposed sale of securities
  • 08.06.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
  • 08.06.2026 - 8-K Current report
  • 08.06.2026 - EX-99.1 EX-99.1
  • 07.17.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors